Protein at Menopause Isn't About Weight. Here's What It's Actually For
I know, I know, we are absolutely inundated with protein advice in midlife.
Most of the conversation about protein at midlife lives inside diet culture. Hit your macros. Build a better body. Lose the weight you gained in perimenopause.
That framing misses almost everything that actually matters — especially for people managing hypermobility, dysautonomia, or MCAS alongside the menopause transition.
Protein is worth paying attention to right now. But not for the reasons most content suggests.
What estrogen has to do with your muscles
Estrogen isn't just a reproductive hormone. It plays an active role in how your body builds and maintains muscle tissue.
As estrogen declines across the menopause transition, the rate at which muscle mass is lost accelerates. Research shows meaningful reductions in lean and muscle mass across the perimenopausal and postmenopausal transition compared to earlier in life. Estradiol acts on muscle cells directly, and its decline affects how muscle protein is maintained and broken down. And unlike some of the other changes that come with this transition, muscle loss compounds — what you lose now affects your strength, stability, and metabolic function for years afterward.
Adequate protein intake is one of the most direct tools for slowing this process. It doesn't reverse declining estrogen. But it gives your body the raw material it needs to maintain muscle at a time when that maintenance requires more effort than it used to.
For hypermobile bodies, this matters more
Most people think about muscle in aesthetic terms, or in terms of general fitness. In hypermobile bodies, muscle plays a more specific role: it's structural support.
Joints in hEDS and HSD have less passive stability from connective tissue than average. Muscle picks up that slack. The muscles surrounding a hypermobile joint are doing a job that ligaments and tendons would normally share — and when muscle mass declines, that job doesn't disappear. It just gets harder to do with fewer resources.
This is part of why people with hEDS often notice joint pain and instability worsening during the menopause transition, even without a clear injury or new diagnosis. Hormonal sensitivity in this population is well-documented, and the shift in estrogen's influence on muscle maintenance is a plausible contributing factor — though the research specifically linking menopause to worsening joint instability in hEDS is still limited. What we do know is that muscle is central to the treatment approach for hypermobility at any stage, and that protecting it becomes more effortful after menopause.
Protein isn't a cure for hypermobility. But it's one of the foundational inputs for the muscle that does the stabilizing work.
Protein, mood, and energy
Protein is made up of amino acids, and some of those amino acids are precursors to neurotransmitters involved in mood and energy regulation — tryptophan feeds into serotonin pathways, and tyrosine into dopamine.
Although the relationship likely isn't as straightforward as a more-in, more-available equation, we do know that adequate protein intake is a necessary component for neurotransmitter production.
Not only that, but protein helps stabilize blood sugar. Adding protein to a carbohydrate-rich meal meaningfully reduces the post-meal glucose spike. For people whose energy is already variable and unpredictable, a flatter blood sugar curve is worth protecting — and that's a practical benefit with strong evidence behind it.
What "adequate" actually means
Protein recommendations vary across sources, and the research on exactly how much is optimal for people in the menopause transition is still developing. What's consistent across expert consensus is that general population guidelines tend to underestimate needs for this life stage. Most evidence in this area points toward something meaningfully above the standard daily reference value — at least 1.0–1.2 gram per kilogram of body weight per day for postmenopausal people. That typically translates to about 90 grams of protein daily. (Quick note: if you have advanced kidney disease, your protein goal might look different.)
A practical starting point without precision tracking: aim for a palm-sized portion of protein at each meal. Protein-rich foods include meats, fish, eggs, lentils, beans, tofu, cottage cheese, and Greek yogurt.
Some data suggest that spreading protein across meals rather than loading it toward dinner is associated with higher lean mass and muscle strength. It's a reasonable practical approach, but not a definitive rule. If high-protein breakfasts are a no-go for you, you can make up your intake throughout the day.
This is also where variable capacity makes things harder. On low-energy days, cooking a high-protein meal may not be realistic. On high-symptom days, appetite may be suppressed. Having a few reliable, low-effort protein options ready for those days — rotisserie chicken, hard-boiled eggs, collagen in your coffee or a pea protein smoothie — is a form of planning that matters as much as knowing the target.
MCAS considerations
For people with MCAS, some high-protein foods are also high-histamine: aged cheeses, canned fish, deli meats, and leftovers that have been stored for more than a day or two. This doesn't mean protein is off the table. It means the sources need to be chosen with your individual triggers in mind.
Freshly cooked meat and fish, eggs, legumes, and certain dairy products tend to be better tolerated. Freezing fresh meat and fish immediately and cooking from frozen can help reduce histamine accumulation. A protein shake with a short ingredient list may also be a useful tool on days when cooking isn't accessible — if you've found a brand you tolerate.
What this is not
This is not a macro-tracking protocol. It's not a weight loss strategy. It's not a recommendation to push through nausea or eat more than feels comfortable in order to hit a number.
It's a reframe: protein at this stage is structural and functional. It's the input your body uses to maintain the muscle that stabilizes your joints, supports your mood and energy, and gives your metabolism something to work with at a time when estrogen is no longer doing as much of that work as it used to.
More of what helps, at most meals, as often as capacity allows.
If you're managing hypermobility, MCAS, dysautonomia, or dysautonomia alongside perimenopause or menopause — and you're tired of advice that wasn't built for your body — The BENDY Method was designed specifically for you.
It's a 12-week habit-based course that builds nineteen evidence-informed habits across nutrition, sleep, nervous system regulation, movement, and long-term health planning. Each one is designed to flex with variable capacity, not demand consistency you can't always give.
Join the waitlist to be first to know when enrollment opens.
References
Menzies C, Bowtell R, Shur N, Brook MS. Menopause, Female Sex Hormones, Skeletal Muscle Mass and Muscle Protein Turnover in Humans. Journal of Cachexia, Sarcopenia and Muscle. 2026;17(1):e70232.
Nappi RE, Chedraui P, Lambrinoudaki I, Simoncini T. Menopause: A Cardiometabolic Transition. The Lancet Diabetes & Endocrinology. 2022;10(6):442–456.
Lu L, Tian L. Postmenopausal Osteoporosis Coexisting With Sarcopenia: The Role and Mechanisms of Estrogen. The Journal of Endocrinology. 2023;259(1):e230116.
Rizzoli R, Stevenson JC, Bauer JM, et al. The Role of Dietary Protein and Vitamin D in Maintaining Musculoskeletal Health in Postmenopausal Women: A Consensus Statement From the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Maturitas. 2014;79(1):122–132.
Campbell WW, Deutz NEP, Volpi E, Apovian CM. Nutritional Interventions: Dietary Protein Needs and Influences on Skeletal Muscle of Older Adults. The Journals of Gerontology: Series A. 2023;78(Suppl 1):67–72.
McKendry J, Lowisz CV, Nanthakumar A, et al. The Effects of Whey, Pea, and Collagen Protein Supplementation Beyond the Recommended Dietary Allowance on Integrated Myofibrillar Protein Synthetic Rates in Older Males: A Randomized Controlled Trial. The American Journal of Clinical Nutrition. 2024;120(1):34–46.
Li J, Jiang L, Saquib N, et al. Estimating the Effect of Hypothetical Dietary Protein Interventions on Changes in Body Composition of Postmenopausal Women Over 3 Years Using Data From the Women's Health Initiative (WHI) Study. International Journal of Obesity. 2026;50(3):609–617.
Paddon-Jones D, Campbell WW, Jacques PF, et al. Protein and Healthy Aging. The American Journal of Clinical Nutrition. 2015;101(6):1339S–1345S.
Farsijani S, Morais JA, Payette H, et al. Relation Between Mealtime Distribution of Protein Intake and Lean Mass Loss in Free-Living Older Adults of the NuAge Study. The American Journal of Clinical Nutrition. 2016;104(3):694–703.
Farsijani S, Payette H, Morais JA, et al. Even Mealtime Distribution of Protein Intake Is Associated With Greater Muscle Strength, but Not With 3-Y Physical Function Decline, in Free-Living Older Adults: The NuAge Study. The American Journal of Clinical Nutrition. 2017;106(1):113–124.
Agergaard J, Justesen TEH, Jespersen SE, et al. Even or Skewed Dietary Protein Distribution Is Reflected in the Whole-Body Protein Net-Balance in Healthy Older Adults: A Randomized Controlled Trial. Clinical Nutrition. 2023;42(6):899–908.
Kim IY, Schutzler S, Schrader AM, et al. Protein Intake Distribution Pattern Does Not Affect Anabolic Response, Lean Body Mass, Muscle Strength or Function Over 8 Weeks in Older Adults: A Randomized-Controlled Trial. Clinical Nutrition. 2018;37(2):488–493.
Parker G, Brotchie H. Mood Effects of the Amino Acids Tryptophan and Tyrosine. Acta Psychiatrica Scandinavica. 2011;124(6):417–426.
Wurtman RJ, Fernstrom JD. Control of Brain Monoamine Synthesis by Diet and Plasma Amino Acids. The American Journal of Clinical Nutrition. 1975;28(6):638–647.
Wolever TM, Zurbau A, Koecher K, Au-Yeung F. The Effect of Adding Protein to a Carbohydrate Meal on Postprandial Glucose and Insulin Responses: A Systematic Review and Meta-Analysis of Acute Controlled Feeding Trials. The Journal of Nutrition. 2024;154(9):2640–2654.
Dao GM, Shaw CS, Betik AC, et al. Mechanistic Insights Into Postprandial Insulin-Glucagon Interactions and Their Impact on Glucose Flux After Protein-Glucose Coingestion in Humans. Diabetes. 2025;74(11):1946–1956.
Yew KS, Kamps-Schmitt KA, Borge R. Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders. American Family Physician. 2021;103(8):481–492.
Hakim A. Hypermobile Ehlers-Danlos Syndrome. GeneReviews. Updated 2024 Feb 22.
Eichinger JK, Byrd RL, Bailey EP, et al. Orthopaedic Manifestations in Hypermobile Ehlers-Danlos Syndrome. The Journal of Bone and Joint Surgery. 2025.
Hugon-Rodin J, Lebègue G, Becourt S, Hamonet C, Gompel A. Gynecologic Symptoms and the Influence on Reproductive Life in 386 Women With Hypermobility Type Ehlers-Danlos Syndrome: A Cohort Study. Orphanet Journal of Rare Diseases. 2016;11(1):124.
Gilligan G, Galindez-Costa MF. Histamine Intolerance: A Pioneering Report on the Oral Manifestations of a Complex Systemic Disorder. Oral Diseases. 2025;31(10):2857–2864.
Critchlow AJ, Alexander SE, Hiam DS, et al. Associations Between Female Sex Hormones and Skeletal Muscle Ageing: The Baltimore Longitudinal Study of Aging. Journal of Cachexia, Sarcopenia and Muscle. 2025;16(3):e13786.